Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs > Nuvilex, Inc. (NVLX)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
Member Level 
Followed By 1,141
Posts 117,571
Boards Moderated 9
Alias Born 01/25/09
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/17/2014 4:00:54 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 10/17/2014 5:59:23 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 10/17/2014 5:59:23 AM
Nuvilex Secures Worldwide License for Insulin-Producing Cells for Use in Developing Diabetes Treatment "InvestorsHub NewsWire" - 10/16/2014 9:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 10/15/2014 2:13:17 PM
Nuvilex Applies to FDA for Orphan Drug Designation for its Cell-in-a-Box® Treatment for Pancreatic Cancer "InvestorsHub NewsWire" - 10/13/2014 9:00:00 AM
Nuvilex Appoints Dr. Matthias Löhr as Chairman of Scientific Advisory Board "InvestorsHub NewsWire" - 10/6/2014 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/3/2014 5:15:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/25/2014 9:07:45 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/15/2014 8:24:01 AM
Nuvilex Aims for Market Exclusivity with Orphan Drug Status While Eyeing Larger Cancer Market for Cell-in-a-Box Technology "InvestorsHub NewsWire" - 9/5/2014 9:00:00 AM
Nuvilex Submits Application for Orphan Drug Designation to the EMA for its Cell-in-a-Box® Treatment for Pancreatic Cancer "InvestorsHub NewsWire" - 9/2/2014 1:26:20 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 8/4/2014 8:12:35 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 7/30/2014 3:24:07 PM
Nuvilex and Austrianova Announce Results of Clinical Trial in Dogs with Mammary Tumors Treated With Cell-in-a-Box(R) Plus Cyc... "GlobeNewswire Inc." - 7/17/2014 9:00:00 AM
Nuvilex Provides Shareholder Update on Milestone Accomplishments "GlobeNewswire Inc." - 7/14/2014 9:00:00 AM
Nuvilex Scheduled to Begin Preclinical Studies in Early August "GlobeNewswire Inc." - 7/9/2014 9:00:00 AM
Nuvilex Executives Attend 2014 BIO International Convention "GlobeNewswire Inc." - 7/1/2014 9:00:00 AM
Nuvilex Inc., TD2 and the PCRT Should Draw Great Interest to the Company's Pancreatic Cancer Treatment "Marketwired" - 6/20/2014 9:00:00 AM
Nuvilex Heads to the Clinic With an Opportunity to Treat a Wider Range of Cancers "Marketwired" - 6/12/2014 9:00:00 AM
Nuvilex CEO and COO Discuss Preclinical and Clinical Trials, Orphan Drug Status, Funding and Much More in Interview "Marketwired" - 6/4/2014 8:30:00 AM
Nuvilex Now Has Access to $50 Million With New Banking Agreement "Marketwired" - 6/2/2014 9:00:00 AM
Nuvilex to Present at the LD MICRO Invitational Conference on June 4, 2014 "GlobeNewswire Inc." - 5/30/2014 9:00:00 AM
Nuvilex Enters Into an At the Market Banking Agreement With Chardan Capital Markets "GlobeNewswire Inc." - 5/29/2014 10:01:44 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/29/2014 6:01:02 AM
NYC Trader Member Level  Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 27209 
NVLX
Link: http://www.otcmarkets.com/stock/NVLX/company-info
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website: http://www.nuvilex.com
Incorporated In: NV, USA


Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist